12/21/20 Victorian Cancer Biobank (VCB) profile uploaded

VCB is one of the largest multi-center collection facilities of its kind in the world, collecting tissue and blood from donors at 26 public & private hospitals in metropolitan Melbourne. VCB has an open-door policy to public and private investigators or companies that have an ethically approved research project. It is customer-focused with an archival collection of >400,000 biospecimens in various storage formats and can support prospective collections.

Victorian Cancer Biobank (VCB) (Australia)

Database Contact Data

Wayne Ng, PhD 
Manager
Victorian Cancer Biobank
615 St Kilda Rd, 
Melbourne, Victoria 3004 
AUSTRALIA
Phone: +61 3 9514 6179
E-mail: Wayne.Ng@cancervic.org.au

Alternate Contact

Enquiries
Project Manager
Victorian Cancer Biobank
615 St Kilda Rd
Melbourne, Victoria 3004
AUSTRALIA
Phone: +61 3 9514 6186
E-mail: VCBEnquiries@cancervic.org.au

References of Studies Using/Describing Database

1. Lalaoui N, Merino D, Giner G, Vaillant F, Chau D, Liu L, Kratina T, Pal B, Whittle JR, Etemadi N, Berthelet J, Gräsel J, Hall C, Ritchie ME, Ernst M, Smyth GK, Vaux DL, Visvader JE, Lindeman GJ, Silke J. Targeting triple-negative breast cancers with the Smac-mimetic birinapant. Cell Death Differ. 2020 Oct;27(10):2768-2780. 

2. Best SA, Hess JB, Souza-Fonseca-Guimaraes F, Cursons J, Kersbergen A, Dong X, Rautela J, Hyslop SR, Ritchie ME, Davis MJ, Leong TL, Irving L, Steinfort D, Huntington ND, Sutherland KD. Harnessing Natural Killer Immunity in Metastatic SCLC. J Thorac Oncol. 2020 Sep;15(9):1507-1521. 

3. Whittle JR, Vaillant F, Surgenor E, Policheni AN, Giner G, Capaldo BD, Chen HR, Liu HK, Dekkers JF, Sachs N, Clevers H, Fellowes A, Green T, Xu H, Fox SB, Herold MJ, Smyth GK, Gray DHD, Visvader JE, Lindeman GJ. Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer. Clin Cancer Res. 2020 Aug 1;26(15):4120-4134. 

4. Williams DS, Mouradov D, Newman MR, Amini E, Nickless DK, Fang CG, Palmieri M, Sakthianandeswaren A, Li S, Ward RL, Hawkins NJ, Skinner I, Jones I, Gibbs P, Sieber OM. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation. Mod Pathol. 2020 Jul;33(7):1420-1432. 

5. Lung MS, Mitchell CA, Doyle MA, Lynch AC, Gorringe KL, Bowtell DDL; Australian Ovarian Cancer Study Group, Campbell IG, Trainer AH. Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei. BMC Cancer. 2020 May 1;20(1):369. 

6. Dawson CA, Pal B, Vaillant F, Gandolfo LC, Liu Z, Bleriot C, Ginhoux F, Smyth GK, Lindeman GJ, Mueller SN, Rios AC, Visvader JE. Tissue-resident ductal macrophages survey the mammary epithelium and facilitate tissue remodelling. Nat Cell Biol. 2020 May;22(5):546-558. 

7. Williams DS, Mouradov D, Browne C, Palmieri M, Elliott MJ, Nightingale R, Fang CG, Li R, Mariadason JM, Faragher I, Jones IT, Churilov L, Tebbutt NC, Gibbs P, Sieber OM. Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. Mod Pathol. 2020 Mar;33(3):483-495. 

8. Gedye C, Sachchithananthan M, Leonard R, Jeffree RL, Buckland ME, Ziegler DS, Graeber MB, Day BW, McDonald KL, Lasocki A; BCBA Consortium, Nowak AK. Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking. Neurooncol Pract. 2020 Jan;7(1):31-37. 

9. Devereux L, Watson PH, Mes-Masson AM, Luna-Crespo F, Thomas G, Pitman H, Speirs V, Hall AG, Bollinger N, Posada M, Lochmüller H, Thorne H, Eng CB, Riegman PHJ, Ng W, Parry-Jones A. A Review of International Biobanks and Networks: Success Factors and Key Benchmarks-A 10-Year Retrospective Review. Biopreserv Biobank. 2019 Dec;17(6):512-519. 

10. Tie J, Cohen JD, Wang Y, Christie M, Simons K, Lee M, Wong R, Kosmider S, Ananda S, McKendrick J, Lee B, Cho JH, Faragher I, Jones IT, Ptak J, Schaeffer MJ, Silliman N, Dobbyn L, Li L, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer. JAMA Oncol. 2019 Oct 17;5(12):1710–7. 

Subscribe to